References
- Wehling M, Neylon C B., Fullerton M., Bobik A., Funder J. W. Nongenomic effects of aldosterone on intracellular calcium in vascular smooth muscle cells. Circ. Res. 1995; 76: 973–979
- Krozowski Z S., Funder J. W. Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 1983; 80: 6056–6060
- Affiza J. L., Weinberger C., Glaser T. M., Handelin B. L., Housman D. E., Evans R. M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptors. Science 1987; 237: 268–275
- Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R. M. The nuclear receptor superfamily: the second decade. Cell 1995; 83: 835–839
- Myles K., Funder J. W. Type I (mineralocorticoid) receptors in the guinea pig. Am J Physiol 1994; 267: E268–E272
- Naray-Fejes-Toth A., Fejes-Toth G. Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells. Am J Physiol. 1990; 259: F672–F678
- Funder J. W., Pearce P., Myles K., Roy L. P. Apparent mineralocorticoid excess, pseudohypoaldosteronism and urinary electrolyte excretion: towards a redefinition of “mineralocorticoid” action. FASEB J 1990; 4: 3234–3238
- Krozowski Z. S., Stewart P., Obeyesekere V., Li K., Feffari P. Mutations in the 11β hydroxysteroid dehydrogenase Type 2 enzyme associated with hypertension and possibly stillbirth. Clin Exp Hypertens. (this issue)
- Wilson R. C., Krozowski Z. S., Li K., Obeyesekere V., Razzaghy-Azar M. M., Harbison D., Wei J. Q., Shackleton C. H.L., Funder J. W., New M. I. A mutation in the HSDIIB2 gene in a family with Apparent Mineralocorticoid Excess. J Clin Endocrinol Metab 1995; 80: 2263–2266
- Mune T., Rogerson F. M., Nikkila H., Agarwal A. K., White P. C. Human hypertension caused by mutations in the gene encoding the kidney isozyme of 110-hydroxysteroid dehydrogenase. Nat Genet 1995; 10: 394–399
- Wilson R. C., Harbison M. D., Krozowski Z. S., Funder J. W., Shackleton C. H.L., Hanauske-Abel H. M., Wei J. Q., Hertecant J., Moran A., Neiberger R. E., Balfe J. W., Fattach A., Daneman D., Licholai T., New M. I. Several homozygous mutations in the gene for 11β-hydroxysteroid dehydrogenase Type 2 in patients with Apparent Mineralocorticoid Excess. J Clin Endocrinol Metab 1995; 80: 3145–3150
- Albiston A., Obeyesekere V., Smith R., Krozowski Z. S. Cloning and tissue distribution of the human 11-β hydroxysteroid dehydrogenase type II enzyme. Mol Cell Endocrinol 1994; 105: R11–R17
- Funder J. W. Enzymes and receptors: challenges and future directions. Steroids 1994; 59: 164–169
- Funder J. W., Myles K. Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies. Endocrinology 1996, in press.
- Gomez-Sanchez E. P., Venkataraman M. T., Thwaites D., Fort C. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol 1990; 258: E649–E653
- Gomez-Sanchez E. P., Fort C., Thwaites D. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats. Am J Physiol 1992; 262: E96–E99
- Gomez-Sanchez E. P., Fort C. M., Gomez-Sanchez C. E. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. Am J Physiol 1990; 258: E482–E484
- Brilla C. G., Weber K. T. Mineralocorticoid excess, dietary sodium and myocardial fibrosis. J Lab Clin Med 1992; 120: 893–901
- Young M. J., Funder J. W. The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt induced cardiac fibrosis. Am J Physiol 1996, in press.
- Young M., Head G., Funder J. W. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol 1995; 269: E657–E662
- Young M, Fullerton M., Dilley R., Funder J. W. Mineralocorticoids, hypertension and cardiac fibrosis. J Clin Invest 1994; 93: 2578–2583
- Guarda E., Myers P., Brilla C., Tyagi S., Weber K. T. Endothelial cell induced modulation of cardiac fibroblast collagen metabolism. Cardiovasc Res. 1993; 27: 1004–1008
- Fullerton M. J., Funder J. W. Aldosterone and cardiac fibrosis: in vitro studies. Cardiovasc Res. 1994; 28: 1863–1867
- Sato A., Funder J. W. High glucose stimulates aldosterone-induced hypertrophy via Type I mineralocorticoid receptors in neonatal rat cardiomyocytes. Endocrinology 1996, in press.
- Kageyama Y., Suzuki H., Saruta T. Role of glucocorticoid in the development of glycyrrhizin-induced hypertension. Clin Exp Hyperten. 1994; 16: 761–778